Infrared spectroscopy of human bone marrow: evidence of structural changes during acute leukemia
Gehan A. Raouf, W.F. Elkhateeb, H. Toumah, M. Quari, Soad Khalil Al Jaouni, K. Elkebba, Taha Kumosani
Abstract
Gehan A. Raouf, W.F. Elkhateeb, H. Toumah, M. Quari, Soad Khalil Al Jaouni, K. Elkebba, Taha Kumosani
Abstract
Fourier transform infrared (FTIR) spectroscopy was explored as a means to distinguish newly diagnosed of acute lymphoblastic leukemia from disease free bone marrow samples. Characteristic bands alterations were identified in both healthy and diseased samples arising from cellular protein, lipid and DNA. There were specific changes that affected the secondary structure of proteins that appeared in the FTIR spectra and confirmed with the second derivative analysis. The overall protein structure in the control sample consists primarily of α-helix, whereas in ALL sample it has a relatively high proportion of anti-parallel β-sheet protein constituents presumably due to leukemia. Different absorbance's ratios for specific bands were calculated and plotted versus the patient samples. There are significant fluctuations in the ratios under investigation which can be attributed to the changes in the biomolecular structure between normal and leukemia samples. Our results indicate that the absorbance of amide A and B are in the range 3,340-3,000, the lipid/protein ratio and the phosphate/amide II ratio are all yielding statistically significant differences parameters, that it can be used as a biomarker in differentiating acute leukemia from leukemia free bone marrow.
OpenAlex reports 7 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Fourier transform infrared (FTIR) spectroscopy was explored as a means to distinguish newly diagnosed of acute lymphoblastic leukemia from disease free bone marrow samples. Characteristic bands alterations were identified in both healthy and diseased samples arising from cellular protein, lipid and DNA. There were specific changes that affected the secondary structure of proteins that appeared in the FTIR spectra and confirmed with the second derivative analysis. The overall protein structure in the control sample consists primarily of α-helix, whereas in ALL sample it has a relatively high proportion of anti-parallel β-sheet protein constituents presumably due to leukemia. Different absorbance's ratios for specific bands were calculated and plotted versus the patient samples. There are significant fluctuations in the ratios under investigation which can be attributed to the changes in the biomolecular structure between normal and leukemia samples. Our results indicate that the absorbance of amide A and B are in the range 3,340-3,000, the lipid/protein ratio and the phosphate/amide II ratio are all yielding statistically significant differences parameters, that it can be used as a biomarker in differentiating acute leukemia from leukemia free bone marrow.
Key concepts: Absorbance, Leukemia, Fourier transform infrared spectroscopy, Bone marrow, Chemistry, Protein secondary structure, Infrared spectroscopy, Spectroscopy